Cargando…

Hepatocellular carcinoma occurrence in DAA-treated hepatitis C virus patients: Correlated or incidental? A brief review

Hepatitis C virus (HCV) chronic infection induces liver fibrosis and cirrhosis but is also responsible for a significant portion of hepatocellular carcinoma (HCC) occurrence. Since it was recognized as a causative factor of chronic hepatitis, there have been multiple efforts towards viral eradicatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gigi, Eleni, Lagopoulos, Vasileios I, Bekiari, Eleni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2018
Materias:	Minireviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6177564/ https://www.ncbi.nlm.nih.gov/pubmed/30310537 http://dx.doi.org/10.4254/wjh.v10.i9.595

Ejemplares similares

Association between direct-acting antiviral agents in hepatitis C virus treatment and hepatocellular carcinoma occurrence and recurrence: The endless debate
por: Kamal, Ahmed, et al.
Publicado: (2022)

Risk of hepatocellular carcinoma after hepatitis C virus cure
por: Luna-Cuadros, Maria Alejandra, et al.
Publicado: (2022)

Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection
por: Irshad, Mohammad, et al.
Publicado: (2017)

Epidemiologic and socioeconomic factors impacting hepatitis B virus and related hepatocellular carcinoma
por: Gnyawali, Bipul, et al.
Publicado: (2022)

Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm?
por: Meringer, Hadar, et al.
Publicado: (2019)

Hypofractionated particle beam therapy for hepatocellular carcinoma–a brief review of clinical effectiveness
por: Hsu, Che-Yu, et al.
Publicado: (2019)

Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?
por: Butt, Amna Subhan, et al.
Publicado: (2018)

Persistent risk for new, subsequent new and recurrent hepatocellular carcinoma despite successful anti-hepatitis B virus therapy and tumor ablation: The need for hepatitis B virus cure
por: Shinn, Brianna J, et al.
Publicado: (2019)

Hepatocellular carcinoma after direct-acting antiviral hepatitis C virus therapy: A debate near the end
por: Muzica, Cristina Maria, et al.
Publicado: (2020)

Role of fetuin A in the diagnosis and treatment of joint arthritis
por: Pappa, Eleni, et al.
Publicado: (2017)

Surveillance for hepatocellular carcinoma in chronic viral hepatitis: Is it time to personalize it?
por: Demirtas, Coskun Ozer, et al.
Publicado: (2021)

Prediction models of hepatocellular carcinoma development in chronic hepatitis B patients
por: Lee, Hye Won, et al.
Publicado: (2016)

Hepatitis C-related hepatocellular carcinoma in the era of new generation antivirals
por: Baumert, Thomas F., et al.
Publicado: (2017)

Prediction models for development of hepatocellular carcinoma in chronic hepatitis B patients
por: Guo, Jiang, et al.
Publicado: (2021)

Current status of radical laparoscopy for treating hepatocellular carcinoma with portal hypertension
por: Shen, Ze-Feng, et al.
Publicado: (2021)

Review on hepatitis B virus precore/core promoter mutations and their correlation with genotypes and liver disease severity
por: Kumar, Rajesh
Publicado: (2022)

Treatment of hepatitis C virus genotype 4 in the DAA era
por: Di Biagio, Antonio, et al.
Publicado: (2018)

Hepatitis B virus pathogenesis: Fresh insights into hepatitis B virus RNA
por: Sekiba, Kazuma, et al.
Publicado: (2018)

Correlation of molecular alterations with pathological features in hepatocellular carcinoma: Literature review and experience of an Italian center
por: Maloberti, Thais, et al.
Publicado: (2022)

Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows
por: Guarino, Maria, et al.
Publicado: (2018)

Treatment for hepatocellular carcinoma with tumor thrombosis in the hepatic vein or inferior vena cava: A comprehensive review
por: Zhang, Zun-Yi, et al.
Publicado: (2021)

Incidental radiological findings suggestive of COVID-19 in asymptomatic patients
por: Romeih, Marwa, et al.
Publicado: (2022)

Management of incidentally discovered appendiceal neuroendocrine tumors after an appendicectomy
por: Muñoz de Nova, José Luis, et al.
Publicado: (2022)

Challenge of managing hepatitis B virus and hepatitis C virus infections in resource-limited settings
por: Said, Zeinab Nabil Ahmed, et al.
Publicado: (2022)

Impact of hepatitis B virus infection on hepatic metabolic signaling pathway
por: Shi, Yi-Xian, et al.
Publicado: (2016)

Metabolic aspects of hepatitis C virus
por: El-Kassas, Mohamed, et al.
Publicado: (2022)

Median arcuate ligament syndrome often poses a diagnostic challenge: A literature review with a scope of our own experience
por: Giakoustidis, Alexandros, et al.
Publicado: (2023)

Hepatitis B virus reactivation in rheumatoid arthritis
por: Wu, Ya-Li, et al.
Publicado: (2022)

Nutritional therapy for hepatocellular carcinoma
por: Ruiz-Margáin, Astrid, et al.
Publicado: (2021)

Immunotherapy for recurrent hepatocellular carcinoma
por: Bhatt, Ahan, et al.
Publicado: (2023)

Current treatment for hepatitis C virus/human immunodeficiency virus coinfection in adults
por: Laiwatthanapaisan, Ratchapong, et al.
Publicado: (2021)

Pancreatic transplantation: Brief review of the current evidence
por: Aref, Ahmed, et al.
Publicado: (2019)

Hepatitis D virus and liver transplantation: Indications and outcomes
por: Muhammad, Haris, et al.
Publicado: (2021)

Treatment of hepatitis B virus infection in children and adolescents
por: Stinco, Mariangela, et al.
Publicado: (2021)

Neurological and psychiatric effects of hepatitis C virus infection
por: Faccioli, Jessica, et al.
Publicado: (2021)

Prevention of vertical transmission of hepatitis B virus infection
por: Veronese, Piero, et al.
Publicado: (2021)

Neurological manifestations of hepatitis E virus infection: An overview
por: Jha, Ashish Kumar, et al.
Publicado: (2021)

Human immune repertoire in hepatitis B virus infection
por: Zhan, Qiao, et al.
Publicado: (2021)

The Impact of Hepatitis C Virus (HCV) Treatment with Direct-Acting (DAA) on the Incidence of Hepatocellular Carcinoma (HCC) in Patients with Advanced Liver Disease
por: De Comarmond, Charles, et al.
Publicado: (2017)

Hepatitis B: Who should be treated?-managing patients with chronic hepatitis B during the immune-tolerant and immunoactive phases
por: Kawanaka, Miwa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_la1ue8ehvvbb361mh4l4fio1h0